More Physiologically-Relevant Cellular Assays for Cardio and Neurotoxicity Testing- An Interview With Susanne Bremer-Hoffmann
Add bookmark
Pharma IQ:How are you developing more physiologically-relevant cellular assays for cardio and neurotoxicity testing?
Susanne Bremer-Hoffmann:In the last 3 years we have evaluated the potential of stem cells for cellular assays for cardio- and neurotoxicity testing in the framework of FP7 projects such as SCR&Tox and DETECTIVE in order to obtain standardized human cells in sufficient amounts to allow investigations of the mechanisms of toxicity. In the area of neurotoxicity, we have used...
